A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAura Biosciences
About this trial
AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial. There are no required interventions or use of AU-011 (bel-sar) in this long-term follow-up study
Eligibility criteria
Qualifiers
Have received bel-sar or sham treatment in the Aura-sponsored clinical trial AU-011-301.
Be willing and able to consent to the AU-011-403 study.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Observational
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov